09/08/2020 12:00 AM EDT
Source: Infectious Diseases Society of America (IDSA). Published: 9/8/2020. The overarching goal of this guidance is to assist clinicians – including those with and without infectious diseases expertise – in selecting antibiotic therapy for infections caused by ESBL-E, CRE, and DTR-P. aeruginosa. The guidance is framed as answers to a series of clinical questions, each of which can stand on its own. (Text)
No hay comentarios:
Publicar un comentario